Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KAT2B | Q92831 | 10/20 | 0.53 |
| ▸ | GSK3B | P49841 | 2/20 | 0.42 |
| ▸ | DAO | P14920 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | PRKCA | P17252 | 1/20 | 0.40 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.38 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.38 |
| ▸ | EP300 | Q09472 | 1/20 | 0.38 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.38 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2109583 | 0.87 | KAT2B (0.56) | KAT2BGSK3BALDH1A1PRKCAALDH2 | |
| SCHEMBL678175 | 0.86 | KAT2B (0.58) | KAT2BEP300CREBBPKAT2A | |
| SCHEMBL3655957 | 0.76 | ALDH1A1 (0.57) | KAT2BALDH1A1EP300CREBBPKAT2A | |
| SCHEMBL7628912 | 0.76 | ALDH1A1 (0.51) | KAT2BGSK3BDAOALDH1A1ALDH2 | |
| SCHEMBL9565202 | 0.74 | KAT2B (0.79) | KAT2BALDH1A1 | |
| SCHEMBL9854210 | 0.74 | KAT2B (0.50) | KAT2BDAOALDH1A1TAAR1 | |
| SCHEMBL11189889 | 0.73 | KAT2B (0.77) | KAT2BGSK3BALDH1A1 | |
| SCHEMBL9234887 | 0.73 | KAT2B (0.61) | KAT2B | |
| SCHEMBL5593712 | 0.72 | KAT2B (0.55) | KAT2BGSK3BALDH1A1EP300CREBBP | |
| SCHEMBL80967 | 0.72 | KAT2B (0.58) | KAT2BGSK3BALDH1A1PRKCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020128311-A1 | Halocyanoacetamide antimicrobial compositions | GIRONDA KEVIN F (US) | 2002-09-12 | — | — | US | claimed |
| CN-1362018-A | Halocyanoacetamide antimicrobial composition | ROHM & HAAS (US) | 2002-08-07 | — | — | CN | claimed |
| US-5073582-A | MILDEW RESISTANT PAINT COMPOSITIONS COMPRISING AN ISOTHIAZOLONE AND A WATER-INSOLUBLE COPPER COMPOUND, ARTICLES, AND METHODS | ROHM AND HAAS COMPANY (US) | 1991-12-17 | — | — | US | claimed |
| EP-0408215-A1 | Mildew resistant paint compositions | ROHM AND HAAS COMPANY (US) | 1991-01-16 | — | — | EP | claimed |
| EP-4227372-A1 | A WHITE PAINT COMPOSITION | Vecor IP Holdings Limited (HK) | 2023-08-16 | — | — | EP | disclosed |
| WO-2023077174-A1 | A PAINT COMPOSITION | VECOR IP HOLDINGS LIMITED (CN) | 2023-05-04 | — | — | WO | disclosed |
| CN-1303882-C | Halocyanoacetamide antimicrobial composition | ROHM & HAAS (US) | 2007-03-14 | — | — | CN | disclosed |
| CN-1467255-A | Stabilized coating compositions containing isothiazolone | 罗姆和哈斯公司 | 2004-01-14 | — | — | CN | disclosed |
| US-20030232906-A1 | Stabilized coating compositions containing isothiazolone | GHOSH TIRTHANKAR (US) | 2003-12-18 | — | — | US | disclosed |
| EP-1369461-A1 | Stabilized coating compositions containing isothiazolone | ROHM AND HAAS COMPANY (US) | 2003-12-10 | — | — | EP | disclosed |
| US-20020128311-A1 | Halocyanoacetamide antimicrobial compositions | GIRONDA KEVIN F (US) | 2002-09-12 | — | — | US | disclosed |
| CN-1362018-A | Halocyanoacetamide antimicrobial composition | ROHM & HAAS (US) | 2002-08-07 | — | — | CN | disclosed |
| EP-1219172-A1 | Halocyanoacetamide antimicrobial compositions | ROHM AND HAAS COMPANY (US) | 2002-07-03 | — | — | EP | disclosed |
| EP-0408215-A1 | Mildew resistant paint compositions | ROHM AND HAAS COMPANY (US) | 1991-01-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020128311-A1 | Halocyanoacetamide antimicrobial compositions | HDHD5, DGKI, DAGLA | KAT2B 1127/4885GSK3B 4664/4885DAO 1933/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.